Beta Bionics Inc (BBNX) Stock Price, Quote & News

Company Profile

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin with...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 427 7785

Website: www.betabionics.com

Address:

11 Hughes, Irvine, United States

MarketBeat May. 13 at 6:06 AM

https://marketbeat.com/a/8651341/ $BBNX Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans

0 · Reply

deepthinker May. 10 at 3:18 PM

$BBNX I would be surprised if we don’t get a bid given the crushed stock price here. Easy to consolidate and clean up the SG&A. Toss the iLet in another bag. Too many players in this space.

0 · Reply

deepthinker May. 7 at 1:45 PM

$BBNX My hunch is this company could be in play here. Tandem has supply and IP issues. DEKA is private. Minimed is still owned by Medtronic.

0 · Reply

ScoutWatch12 May. 7 at 2:18 AM

$BBNX as a T1D using this pump - we aren’t wrong, just early. (It’s the same thing!! I know) patience. This is unbelievably ahead of tandem, omnipod, twist, and the unmentionables. They must figure out how to get the doctors onboard. The pump castrates the endocrinologist and they don’t like that at all.

2 · Reply

deepthinker May. 6 at 7:32 PM

$PODD Who’s likely not in play: Tandem, DEKA, MiniMed. Who’s in play: $BBNX

0 · Reply

deepthinker May. 6 at 7:01 PM

$BBNX Given Insulet’s slowing growth arc, they may look to buy growth.

0 · Reply

firewulf May. 5 at 11:39 PM

$BBNX remember when the CFO sold 30 percent of his stock at $30. Love the comments defending this company though

0 · Reply

deepthinker May. 2 at 3:42 PM

$BBNX I don’t quite understand the strategy here. They’re going to try and build revenues even if it drains cash to zero in 7 quarters? What happens then? In my opinion, there are just too many companies in this space. It’s causing spend to get out of control. The first victim will be this company. They should reverse course and go for profitability rather than growth.

4 · Reply

BillionerOfKing May. 2 at 2:30 AM

$BBNX Current Stock Price: $10.27 Contracts to trade: $10.0 BBNX May 15 2026 Call Entry: $0.55 Exit: $0.91 ROI: 66% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Arcides Apr. 28 at 7:26 PM

$BBNX medical devices stocks are trash...

1 · Reply

Beta Bionics Transcript: Bank of America Global Healthcare Conference 2026

Apr 27, 2026, 4:25 PM EDT - 15 days ago

Beta Bionics to Present at the Bank of America Securities Health Care Conference

2026-04-22T11:50:58.000Z - 21 days ago

Beta Bionics price target lowered to $20 from $22 at Stifel

2026-04-22T11:09:16.000Z - 21 days ago

Beta Bionics price target lowered to $20 from $32 at Piper Sandler

2026-04-21T20:31:34.000Z - 21 days ago

Beta Bionics reports Q1 EPS (49c), consensus (45c)

Apr 21, 2026, 4:30 PM EDT - 21 days ago

Beta Bionics Earnings Call Transcript: Q1 2026

2026-04-21T20:28:56.000Z - 21 days ago

Beta Bionics sees FY26 revenue $131M-$136M, consensus $132.58M

Apr 21, 2026, 4:03 PM EDT - 21 days ago

Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

2026-04-15T12:36:49.000Z - 4 weeks ago

Beta Bionics price target lowered to $18 from $25 at Truist

Apr 14, 2026, 9:00 AM EDT - 4 weeks ago

Beta Bionics, Inc. Investigated by the Portnoy Law Firm

Mar 30, 2026, 4:11 PM EDT - 6 weeks ago

Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026

2026-03-24T12:46:35.000Z - 7 weeks ago

Beta Bionics pullback an ‘overreaction,’ says Lake Street

2026-03-13T15:00:31.000Z - 2 months ago

Beta Bionics management to meet virtually with Lake Street

Mar 4, 2026, 10:30 AM EST - 2 months ago

Beta Bionics Transcript: TD Cowen 46th Annual Health Care Conference

2026-02-24T22:20:44.000Z - 2 months ago

Beta Bionics files automatic mixed securities shelf

Feb 19, 2026, 4:05 PM EST - 2 months ago

Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference

2026-02-18T13:45:50.000Z - 2 months ago

Beta Bionics price target lowered to $20 from $40 at Lake Street

2026-02-18T12:50:59.000Z - 3 months ago

Beta Bionics price target lowered to $14 from $28 at Baird

2026-02-18T11:51:17.000Z - 3 months ago

Beta Bionics price target lowered to $22 from $25 at Stifel

2026-02-17T21:55:25.000Z - 3 months ago

Beta Bionics sees FY26 revenue $130M-$135M, consensus $132.68M

2026-02-17T21:50:27.000Z - 3 months ago

Beta Bionics reports Q4 EPS (30c), consensus (38c)

Feb 17, 2026, 4:30 PM EST - 3 months ago

Beta Bionics Earnings Call Transcript: Q4 2025

Feb 17, 2026, 4:05 PM EST - 3 months ago

Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026

2026-02-09T14:02:04.000Z - 3 months ago

Beta Bionics initiated with a Buy at UBS

2026-02-08T21:15:05.000Z - 3 months ago

Beta Bionics initiated with a Buy at UBS

2026-02-04T13:10:42.000Z - 3 months ago

Beta Bionics price target lowered to $25 from $31 at Stifel

2026-02-02T14:55:34.000Z - 3 months ago

Beta Bionics discloses FDA warning letter

2026-02-02T14:55:21.000Z - 3 months ago

Beta Bionics price target lowered to $25 from $37 at Truist

Jan 21, 2026, 6:15 PM EST - 3 months ago

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Beta Bionics, Inc. (NASDAQ: BBNX)

Jan 15, 2026, 4:03 PM EST - 4 months ago

Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

Jan 15, 2026, 1:36 AM EST - 4 months ago

Beta Bionics, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - BBNX

Jan 8, 2026, 4:04 PM EST - 4 months ago

Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics

Dec 8, 2025, 7:45 AM EST - 5 months ago

Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026

Dec 2, 2025, 4:30 PM EST - 5 months ago

Beta Bionics Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 2:00 PM EST - 6 months ago

Beta Bionics Transcript: Wolfe Research Healthcare Conference 2025

Nov 3, 2025, 4:08 PM EST - 6 months ago

Beta Bionics Announces Participation at Upcoming Investor Conferences

Oct 28, 2025, 4:30 PM EDT - 7 months ago

Beta Bionics Earnings Call Transcript: Q3 2025

Oct 28, 2025, 4:02 PM EDT - 7 months ago

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

Oct 9, 2025, 8:00 AM EDT - 7 months ago

Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025

Sep 8, 2025, 1:50 PM EDT - 8 months ago

Beta Bionics Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 3:45 PM EDT - 8 months ago

Beta Bionics Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Jul 29, 2025, 4:30 PM EDT - 10 months ago

Beta Bionics Earnings Call Transcript: Q2 2025

Jul 29, 2025, 4:02 PM EDT - 10 months ago

Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

Jul 2, 2025, 7:30 AM EDT - 11 months ago

Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025

Jun 22, 2025, 8:00 AM EDT - 11 months ago

Beta Bionics Transcript: Status Update

Jun 19, 2025, 7:00 AM EDT - 11 months ago

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor

May 13, 2025, 12:35 PM EDT - 1 year ago

Beta Bionics Transcript: Bank of America 2025 Healthcare Conference

May 6, 2025, 4:30 PM EDT - 1 year ago

Beta Bionics Earnings Call Transcript: Q1 2025

May 6, 2025, 4:02 PM EDT - 1 year ago

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

Apr 9, 2025, 7:30 AM EDT - 1 year ago

Beta Bionics to Host Investor Event on June 22, 2025

Mar 27, 2025, 4:45 PM EDT - 1 year ago

Beta Bionics Announces Board Appointment of Gerard Michel

Mar 25, 2025, 4:30 PM EDT - 1 year ago

Beta Bionics Earnings Call Transcript: Q4 2024

Mar 25, 2025, 4:02 PM EDT - 1 year ago

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

Feb 27, 2025, 7:00 AM EST - 1 year ago

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Jan 31, 2025, 5:56 PM EST - 1 year ago

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jan 29, 2025, 10:34 PM EST - 1 year ago

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

MarketBeat May. 13 at 6:06 AM

https://marketbeat.com/a/8651341/ $BBNX Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans

0 · Reply

deepthinker May. 10 at 3:18 PM

$BBNX I would be surprised if we don’t get a bid given the crushed stock price here. Easy to consolidate and clean up the SG&A. Toss the iLet in another bag. Too many players in this space.

0 · Reply

deepthinker May. 7 at 1:45 PM

$BBNX My hunch is this company could be in play here. Tandem has supply and IP issues. DEKA is private. Minimed is still owned by Medtronic.

0 · Reply

ScoutWatch12 May. 7 at 2:18 AM

2 · Reply

deepthinker May. 6 at 7:32 PM

$PODD Who’s likely not in play: Tandem, DEKA, MiniMed. Who’s in play: $BBNX

0 · Reply

deepthinker May. 6 at 7:01 PM

$BBNX Given Insulet’s slowing growth arc, they may look to buy growth.

0 · Reply

firewulf May. 5 at 11:39 PM

$BBNX remember when the CFO sold 30 percent of his stock at $30. Love the comments defending this company though

0 · Reply

deepthinker May. 2 at 3:42 PM

4 · Reply

BillionerOfKing May. 2 at 2:30 AM

0 · Reply

Arcides Apr. 28 at 7:26 PM

$BBNX medical devices stocks are trash...

1 · Reply

firewulf Apr. 27 at 4:58 PM

$BBNX 🙏

0 · Reply

PenkeInvesting Apr. 25 at 8:11 PM

Fundamental analysis of $BBNX (Beta Bionics, Inc.) based on financial data and reported results. #BBNX

0 · Reply

jazzv Apr. 24 at 2:04 AM

$BBNX possible cheap target for m&a

0 · Reply

firewulf Apr. 22 at 3:36 PM

$BBNX 😂

0 · Reply

DARKP00L Apr. 22 at 12:39 PM

$BBNX 08:31 on Apr. 22 2026 Stifel Maintains Buy on Beta Bionics, Lowers Price Target to $20 #tradeideas

0 · Reply

PickAlpha Apr. 22 at 12:07 PM

3/5: Beta Bionics reports Q1 2026 sales up 57.00% and raises full-year 2026 guidance as pharmacy-benefit channel growth accelerates. | View: A guidance raise, 57% sales growth and margin expansion are offset by double-digit sequential… $BBNX $DXCM $TNDM $IHI

0 · Reply

Profafa Apr. 21 at 8:20 PM

$BBNX raised guidiance but still down wtf

0 · Reply

StocktwitsEarnings Apr. 21 at 8:12 PM

$BBNX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.49 up 47.31% YoY • Reported revenue of $27.63M up 56.62% YoY • Beta Bionics raised its full year 2026 guidance, now expecting total revenue of $131M to $136M, gross margin of 57.5% to 59.5%, and 37% to 39% of new patient starts reimbursed through the PBP channel.

0 · Reply

jazzv Apr. 21 at 5:35 PM

$BBNX eye on this. looking to get some back sold around 13.

0 · Reply

SuperGreenToday Apr. 17 at 5:29 PM

$BBNX Share Price: $13.03 Contract Selected: Oct 16, 2026 $15 Calls Buy Zone: $0.09 – $0.11 Target Zone: $0.14 – $0.17 Potential Upside: 57% ROI Time to Expiration: 181 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Nasdaqswingtrade Apr. 17 at 2:48 AM

Your opinion for tomorrow trading? $WATT VOLATILITY SPIKE (8%+) $BBNX BREAKOUT MA 50 $ALMU VOLATILITY SPIKE (8%+) $HSAI BREAKOUT MA 50 $UPST VOLATILITY SPIKE (8%+)

2 · Reply

Messerschmittbf109 Apr. 15 at 5:23 PM

$BBNX $IXHL $CRDF Bbnx +50% in three days congrats….

0 · Reply

Market Cap	438.94M
Revenue (ttm)	100.25M
Net Income (ttm)	-73.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-73.02%
Debt to Equity Ratio	0.00

Volume	496,400
Avg Vol	1,058,426
Day's Range	N/A - N/A
Shares Out	44.56M
Stochastic %K	22%
Beta	3.29
Analysts	Strong Sell
Price Target	$20.27